715 SP 15 (Univasc 15 mg)
Generic Name: moexipril
Pill with imprint 715 SP 15 is Pink, Round and has been identified as Univasc 15 mg. It is supplied by Schwarz Pharma.
Univasc is used in the treatment of heart failure; diabetic kidney disease; heart attack; high blood pressure; left ventricular dysfunction and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Univasc 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 715 SP 15
Univasc
- Generic Name
- moexipril
- Imprint
- 715 SP 15
- Strength
- 15 mg
- Color
- Pink
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Angiotensin Converting Enzyme Inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Schwarz Pharma
- Inactive Ingredients
-
lactose, magnesium oxide, crospovidone, magnesium stearate, gelatin, hydroxypropyl cellulose (type h), hypromelloses, polyethylene glycol 6000, titanium dioxide, ferric oxide red
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00091-3715 | Schwarz Pharma Inc. |
| 54569-4276 | A-S Medication Solutions, LLC (repackager) |
More about Univasc (moexipril)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- 2 Reviews
- Drug class: Angiotensin Converting Enzyme Inhibitors
- FDA Alerts (1)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
